This paper presents a proof-of-concept method for classifying chemical compounds directly from NMR data without performing structure elucidation.
Agreeing in principle that there are benefits to data automation is one thing, yet in practice, changing standard processes to implement such automations can be a much more complicated decision to make, especially when lacking the internal expertise to take care of such changes.
Dr. Mark Dixon (Mestrelab) gave a webinar on how identification and/or quantification of components of a mixture in solution is a common problem that a chemist must solve on a frequent basis.
Mnova NMR can handle datasets from the most important NMR vendors. You can see the whole list here. If you have any doubts regarding your datasets and format compatibility with Mnova NMR just contact us.
The demand for, and adoption of lab automated systems has been constantly increasing over the past few years, the market for which is anticipated to grow by 7.6%, up to $9.21 billion, by 2029.
Fragment-based drug discovery (FBDD) and validation of small molecule binders using NMR spectroscopy is an established and widely used method in the early stages of drug discovery. Starting from a library of small compounds, ligand- or protein-observed NMR methods are employed to detect binders, typically weak, that become the starting points for structure-activity relationships (SAR) by NMR.
This is the list of provider data sorted per OS supported by Mnova MSChrom. Note that Mnova 15 does not support Windows x32 formats.
Mnova LC/GC-MS software solutions for your analysis. A popular desktop application, a powerful automation engine, a task-specialized analysis
